How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
Continuous Postive Airway Pressure Market
- By Product Type: Fixed CPAP, Auto CPAP (APAP), Bi-level PAP (BiPAP), Travel CPAP Machines, CPAP Accessories
- By Pressure Range: Low Pressure (4-10 cm H2O), Medium Pressure (11-15 cm H2O), High Pressure (16-20 cm H2O)
- By End User: Homecare Settings, Hospitals, Sleep Clinics, Specialty Respiratory Centers
- By Therapy Type: Obstructive Sleep Apnea Therapy, Central Sleep Apnea Therapy, Complex Sleep Apnea Therapy
- By Interface Type: Nasal Masks, Full Face Masks, Nasal Pillows, Oral Masks
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Fixed CPAP leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 291 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.176 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.184 →
Full report · locked preview
Everything inside the Continuous Postive Airway Pressure Market report
A complete, evidence-based study - 12 chapters and 122 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Product Type 5
Pressure Range 3
End User 4
Therapy Type 3
Interface Type 4
Companies profiled
ResMed Inc.
Philips Respironics
Fisher & Paykel Healthcare Corporation Limited
Drive DeVilbiss Healthcare
3B Medical Inc.
BMC Medical Co. Ltd.
Curative Medical Inc.
Somnetics International Inc.
3M Company (Sleep Apnea Division)
Compumedics Limited
Vyaire Medical Inc.
Invacare Corporation
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →ResMed Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Philips Respironics
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Fisher & Paykel Healthcare Corporation Limited
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Drive DeVilbiss Healthcare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →3B Medical Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →BMC Medical Co. Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Curative Medical Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Somnetics International Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →3M Company (Sleep Apnea Division)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Compumedics Limited
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Vyaire Medical Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Invacare Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Apex Medical Corp.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →DeVilbiss Healthcare LLC
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Lincare Holdings Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$5,371M by 2033 · 3.5% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Fixed CPAP34.8
- Auto CPAP (APAP)9.9
- Bi-level PAP (BiPAP)15.5
- Travel CPAP Machines17.1
- CPAP Accessories22.7
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,350M → $1,937M · 4.6%
Europe$941.1M → $1,290M · 4.0%
Asia Pacific$859.2M → $1,232M · 4.6%
Latin America$531.9M → $654.6M · 2.6%
Middle East and Africa$409.2M → $485.0M · 2.1%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →3.412026
3.432027
3.442028
3.452029
3.462030
3.472031
3.482032
3.492033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- ResMed Inc.25.3
- Philips Respironics12.8
- Fisher & Paykel Healthcare Corporation Limited12.4
- Drive DeVilbiss Healthcare4.5
- 3B Medical Inc.5.8
- BMC Medical Co. Ltd.11.2
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type20.7%
Pressure Range24.5%
End User30.7%
Therapy Type11.2%
Interface Type12.9%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America34.6
- Europe23.0
- Asia Pacific22.0
- Latin America11.7
- Middle East and Africa8.7
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| ResMed Inc. | 89 | 82 | 78 | 81 | 92 | 82 | 84 |
| Philips Respironics | 81 | 75 | 72 | 87 | 84 | 91 | 82 |
| Fisher & Paykel Healthcare Corporation Limited | 81 | 65 | 84 | 73 | 80 | 81 | 77 |
| Drive DeVilbiss Healthcare | 73 | 82 | 71 | 61 | 81 | 66 | 72 |
| 3B Medical Inc. | 59 | 72 | 66 | 67 | 60 | 64 | 65 |
| BMC Medical Co. Ltd. | 46 | 66 | 67 | 53 | 58 | 52 | 57 |
| Curative Medical Inc. | 45 | 65 | 55 | 54 | 51 | 51 | 54 |
| Somnetics International Inc. | 54 | 36 | 53 | 56 | 58 | 36 | 49 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- ResMed Inc.
- Philips Respironics
- Fisher & Paykel Healthcare Corporation Limited
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| ResMed Inc. | ✓ | ✓ | ◐ | ◐ | ✓ | ✓ |
| Philips Respironics | ✓ | ✓ | ✓ | ◐ | ◐ | ✓ |
| Fisher & Paykel Healthcare Corporation Limited | ✓ | ◐ | ✓ | ✓ | ✓ | ✓ |
| Drive DeVilbiss Healthcare | ✓ | ✓ | ◐ | ◐ | ✓ | ◐ |
| 3B Medical Inc. | ◐ | ◐ | ◐ | ◐ | − | − |
| BMC Medical Co. Ltd. | ◐ | − | ◐ | − | ◐ | ◐ |
| Curative Medical Inc. | − | ◐ | ◐ | ◐ | − | ◐ |
| Somnetics International Inc. | ◐ | − | − | ◐ | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1ResMed Inc.84
2Philips Respironics82
3Fisher & Paykel Healthcare Corporation Limited77
4Drive DeVilbiss Healthcare72
53B Medical Inc.65
6BMC Medical Co. Ltd.57
7Curative Medical Inc.54
8Somnetics International Inc.49
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
ResMed Inc.Philips Respironics
Challenger2
Strong scale, closing on the leaders.
Fisher & Paykel Healthcare Corporation LimitedDrive DeVilbiss Healthcare
Contender2
Focused players with pockets of strength.
3B Medical Inc.BMC Medical Co. Ltd.
Niche2
Specialists in a single segment or region.
Curative Medical Inc.Somnetics International Inc.
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Product Type in North America, then scale across Continuous Postive Airway Pressure Market — a $199M beachhead inside a $3.92B market.
Beachhead (SOM)$199Mobtainable near-term
Serviceable (SAM)$1.38Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion87 fit
Fixed CPAP
Best fit — highest urgency & budget in Product Type.
Economic buyer78 fit
Auto CPAP (APAP)
Strong fit — clear ROI and a fast path to value.
End user68 fit
Bi-level PAP (BiPAP)
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Pressure Range & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales43%
Partner / channel30%
Digital / self-serve20%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Continuous Postive Airway Pressure Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified45%
Sales qualified25%
Evaluation12%
Closed-won6%
$21.5KCAC
$83KLTV
3.8:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Continuous Postive Airway Pressure Market is a durable-growth opportunity — $7.34B by 2033, compounding at 8.1%.
TAM · 2025$3.94Btoday
TAM · 2033$7.34Bforecast
CAGR8.1%2027–2033
Cumulative$49.4Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$7.34BTotal addressable market
SAM$2.56BServiceable available market
SOM$557MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →8.1% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$7.34BLarge & growingTAM by 2033 at 8.1% CAGR
$2.56BServiceable nowreachable with today’s model
$557MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$5.72BBear5.3% CAGR
$7.34BBase8.1% CAGR
$9.39BBull10.7% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Pressure Range optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Continuous Postive Airway Pressure Market — a $4.49B market by 2033. Plan: grow share from 10.2% to 18.6%.
Market size · 2033$4.49Btotal addressable
Market CAGR4.0%2027–2033
Target share18.6%from 10.2% today
Revenue ambition$835Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 10.2% | 18.6% | At risk |
| Revenue | $478M | $835M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Behind |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Ahead |
| Gross margin | 28.6% | 44.2% | On track |
| Customer retention | 90.0% | 96.9% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Pressure Range capability
A defensible second engine — invest in Pressure Range to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Pressure Range
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $102M capacity & capability investment
- Greenlight bolt-on M&A in Pressure Range
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownBehind
- Competitive share lossOn track
- Input-cost & supply riskAhead
- Regulatory / policy changeAhead
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Continuous Postive Airway Pressure Market conversation — a $4.64B market you can size, segment and defend in minutes.
Market size · 2033$4.64Btotal opportunity
Growth5.1%CAGR to 2033
Addressable buyers1,411+accounts in scope
Typical ROI5.4×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5.4×return on cost, year one
< 2 mopayback period
$43K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
ResMed Inc.Philips RespironicsFisher & Paykel Healthcare Corporation LimitedDrive DeVilbiss Healthcare3B Medical Inc.BMC Medical Co. Ltd.Curative Medical Inc.Somnetics International Inc.+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Continuous Postive Airway Pressure Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Continuous Postive Airway Pressure Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →Continuous Pressure Laminates Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View reportContinuous Reforming Catalyst Market
Market size, share, segmentation and regional forecast.
$3.4B market · 2025 base year
View reportContinuous Renal Replacement Therapy Machines (CRRT) Market
Market size, share, segmentation and regional forecast.
$1.8B market · 2025 base year
View reportContinuous Side-Sealer Market
Market size, share, segmentation and regional forecast.
$3.9B market · 2025 base year
View reportContinuous Steam Sterilizer Market
Market size, share, segmentation and regional forecast.
$1.0B market · 2025 base year
View reportContinuous Stirred-tank Industrial Aerator Market
Market size, share, segmentation and regional forecast.
$357M market · 2025 base year
View reportContinuous Subcutaneous Insulin Infusion Market
Market size, share, segmentation and regional forecast.
$1.1B market · 2025 base year
View reportContinuous Syringe Market
Market size, share, segmentation and regional forecast.
$469M market · 2025 base year
View reportContinuous Tableting Line Market
Market size, share, segmentation and regional forecast.
$3.9B market · 2025 base year
View reportContinuous Tunnel Washing Machine Market
Market size, share, segmentation and regional forecast.
$946M market · 2025 base year
View reportContinuous Type Blender Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportContinuous Unloaders Market
Market size, share, segmentation and regional forecast.
$2.8B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.